Skip to main content
. 2022 Sep 1;72(3):697–705. doi: 10.1007/s00262-022-03272-8

Fig. 2.

Fig. 2

36-month overall survival A and disease-free survival B comparing vaccine to placebo, and overall survival C and disease-free survival D comparing TLPLDC, TLPLDC + G, and placebo